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Mass spectrometry (MS)-based methods coupled to reverse
phase chromatography separation are a useful technology to
analyze complex peptide pools that are comprised of different
peptides with unrelated sequences. In antigen presentation,
proteasomes generate a set of short peptides that are closely
related and overlapping and in some instances may even have
identical retention times and identical masses. In these situa-
tions, micro-liquid chromatography-MS/MS focused on each
theoretical parent ion followed by manual interpretation opti-
mizes the identification of generated peptides. The results sug-
gest that the degradation of short antigens by the proteasome
occurs by sequential cleavage.
Recognition of virus-infected cells by cytotoxic T lympho-
cytes requires prior proteolytic processing of viral proteins (1).
This degradation generates short peptides that are translocated
to the endoplasmic reticulum lumen by transporters associated
with antigen processing, assembled with major histocompati-
bility complex class I heavy chain and 2-microglobulin, and
transported to the cell membrane (1). In infected cells, process-
ing predominantly takes place in the cytosol by the combined
action of proteasomes and degradative peptidases. Processing
generates a broad diversity of peptides including a small frac-
tion of the correct epitope orN-terminally extended precursors
(1) that are utilized for major histocompatibility complex class
I antigen presentation. These epitope precursor peptides
require N-terminal trimming by aminopeptidases either in the
cytosol or in the endoplasmic reticulum (2). We are interested
in the identification of the set of processed peptides generated
from short viral proteins by antigen processing by the protea-
some and/or other proteases.
In a previous work (3), we studied antigen processing from
recombinant vaccinia viruses encoding two closely related
minigene products encompassing murine cytomegalovirus
pp89 immunodominant nonamer epitope (4). By using prote-
ase inhibitors, we defined a role for proteasomes in physiolog-
ical intracellular antigen processing of short antigens. One of
theminigenes (m19) codes for a 19-mer peptide,MDIGAYPH-
FMPTNLAGDPY. It represents the immunodominant murine
cytomegalovirus 9pp89 epitope (YPHFMPTNL) and the local
flanking amino acids of HBe carrier protein. In addition, it pre-
sents a biterminal alanine spacer between the 9pp89 core and
HBe flanking residues, which was previously reported to
enhance antigenicity (5). In this classic paper Eggers et al. (5)
characterized the proteasome digestion products of this m19
peptide. The authors identified two cleavage products; the 1–14
peptide (MDIGAYPHFMPTNL) as the major degradation
product and also the 9pp89 epitope (6YPHFMPTNL14) were
detected. As the proteasome is a multicatalytic protease with
three different activities (6), some authors have demonstrated a
broad spectrum of processed peptides generated by the action
of this protease on different proteins (reviewed in Ref. 7).
Accordingly, we can expect higher diversity in m19 cleavage
experiments that are revealed with the classic MS2 analysis (5).
In the last years immunoproteomics or mass spectrometry-
based methods to study the targets of the immune response
have been developed (8). With the standard automated micro-
LC-MS/MS scan mode we detected four m19-derived cleavage
products. Therefore we modified this technical approach
involving micro-LC-MS/MS focused on each theoretical
parental cleavage product followed by manual interpretation,
and thus we optimize the detection of generated peptides. This
strategy allow the identification of nine cleavage products.
With these data, we suggest a sequential cleavage model for
proteasome activity on the m19 peptide.
EXPERIMENTAL PROCEDURES
Synthetic Peptides—The peptides were synthesized in an
Applied Biosystems peptide synthesizer model 433A (Foster
City, CA), purified, and found homogeneous by HPLC analysis.
HPLC Analysis of Peptides—Five nanomoles of each synthetic
peptide was analyzed by reverse phase HPLC (SMART system
equipped with a RPC Sephasil C18 SC 2.1/10 column (GE
Healthcare)). The eluents used were: A, 19.6% acetonitrile con-
taining 0.1% trifluoroacetic acid; B, 70% acetonitrile containing
0.1% trifluoroacetic acid. The gradient was 0–31.2% B in 18 min
and 31.2–100% in 4 min, and the flow rate was 210 l/min1.
Several runs were performed with each synthetic peptide, and
their location inside the acetonitrile gradient was reproducible
with a maximum error of one fraction (52 l).
Proteasome Assays—Isolation and purification of 20 S pro-
teasomes from rabbit psoas muscle used were performed
* This work was supported by grants from the Programa Ramón y Cajal,
Comunidad de Madrid, Instituto de Salud Carlos III, Fundación FIPSE, and
Fondo de Investigaciones Sanitarias de la SS (to D. L.) and from the Minis-
terio de Educación y Ciencia, Comunidad de Madrid, and Instituto de Salud
Carlos III (to M. D. V.). The costs of publication of this article were defrayed
in part by the payment of page charges. This article must therefore be
hereby marked “advertisement” in accordance with 18 U.S.C. Section 1734
solely to indicate this fact.
1 To whom correspondence and reprint requests should be addressed. Tel.:
34 91 822 37 08; Fax: 34 91 509 79 19; E-mail: dlopez@isciii.es.
2 The abbreviations used are: MS, mass spectrometry; LC, liquid chromatog-
raphy; ESI, electrospray ionization; IT, ion trap; MALDI-TOF, matrix-assisted
laser desorption/ionization time-of-flight.
THE JOURNAL OF BIOLOGICAL CHEMISTRY VOL. 281, NO. 41, pp. 30315–30318, October 13, 2006
© 2006 by The American Society for Biochemistry and Molecular Biology, Inc. Printed in the U.S.A.
OCTOBER 13, 2006 • VOLUME 281 • NUMBER 41 JOURNAL OF BIOLOGICAL CHEMISTRY 30315










exactly as previously described (9). The reaction conditions for
proteasome were as published (10).
Mass Spectrometry Analysis—MALDI-TOF mass spectrom-
etrywas performed in a Reflex IV instrument (Brucker-Franzen
Analytik, Bremen, Germany) operating in the positive ion
reflection mode. Twenty-five microliters of sample were dried,
resuspended in 1l of 0.1% trifluoroacetic acid in a 2:1 solution
of water:acetonitrile, and mixed with 1 l of saturated -cya-
nohydroxycinnamic acid matrix in the same solution. One
microliter of the mixture was dried and subjected to analysis.
Aliquots of total digestions were dried and dissolved in 10 l
of 0.5% acetic acid in water and sequenced by quadrupole ion
trap micro-HPLC (Biobasic C18 column, 150  0.18 mm
(ThermoElectron, San Jose, CA) electrosprayMS/MS in aDeca
XP LCQ mass spectrometer (Thermo Electron). The eluents
used were: A, 0.5% acetic acid in water; B, 80% acetonitrile con-
taining 0.5% acetic acid. The gradient was 0–40% B in 24 min
and 40–100% in 5min, and the flow rate was 1.5 l/min1.We
used the MS/MS mode focused to each hypothetical parental
peptide with a isolation width (m/z) of 1.5 Da. The charge and
the mass of the ionic species were determined by high resolu-
tion sampling of themass/charge rank. Collision energy and ion
precursor resolution were improved to optimize the fragmen-
tation spectrum.
RESULTS AND DISCUSSION
As a first step, proteasomes were isolated and purified (9).
Next, m19 synthetic peptide was incubated with purified pro-
teasomes. After that, the cleavage products generated by this
protease involved in m19 processing were analyzed by mass
spectrometry. In a first approximation MALDI-MS analysis of
total digestion was carried out. This system allowed the detec-
tion of three different peptidic species derived from the m19
sequence (Fig. 1). Species number 3 had identicalm/z with the
1–14 peptide detected as the major cleavage product by Eggers
et al. (5). To elucidate the nature of the two additional products
detected and verify the nature of
species number 3, MS/MS analysis
was performed. To this end, micro-
HPLC with on-line detection by
ESI-IT MS/MS was performed.
This strategy in addition to the
identification of peptide by frag-
mentation also increases the resolu-
tion of peptide separation before
detection and subsequently
enhances the sensitivity of the
assay. In this automated separation-
detection system, four peptidic
products were unequivocally iden-
tified: the three previously detected
by MALDI mass spectrometry
together with one new shorter pep-
tide (Fig. 2, top). In addition, uncer-
tainties on the nature of species
numbers 1 and 2, inherent to previ-
ousMALDI analysis, were resolved.
In summary, 1–14, 4–14, 5–14, and
6–14 peptides were identified as cleavage products. No pep-
tides were detected that arose from cleavages within the 9pp89
core in both MALDI-TOF and ESI-IT analysis.
Usually the automated MS/MS scan mode allows for the
identification of predominant parental peptidic species, but
we are interested in the identification of the largest spectrum
of products generated by the proteasome activity. The
potential digestion products of m19 are closely related and
the collection is highly complex. Indeed, in the mixture of
digestion products of m19 peptide by the proteasome 35
theoretical different peptides are possible that contain the
cytomegalovirus 6–14 nonamer core, that is that are immu-
nologically relevant. As the m19 sequence presents two Met
(easily oxidized) located at the N terminus and at residue
number 10, all processed relevant peptides could appear also
as the oxidized molecular ion. In addition, five of these pep-
tides present the twoMet residues in their sequence. In sum-
mary, we need to detect 42 distinct molecular ions that cor-
respond to 80 relevant molecular species derived from the
m19 sequence; some of them have the same hydrophobic
properties and some have identical daughter ions produced
by MS fragmentation.
As the hypothetical cleavage products are overlapping
peptides because they have an identical nonamer core and
present staged length, their hydrophobic properties in
reverse phase HPLC could be related. In addition, the two
residues flanking the 9pp89 epitope are symmetrical, and
thus, their corresponding peptides (A9pp89 and 9pp89A or
GA9pp89 and 9pp89AG) present identical HPLC retention
properties as well as m/z values. Previous HPLC separation
analysis (data not shown) indicated a short separation of a
maximum of 4 to 5 fractions between the two extreme pep-
tides, m19 and 9pp89 epitope (6YPHFMPTNL14). This is
true even when the gradient used for elution of the synthetic
peptides from the reverse phase HPLC column was rather
FIGURE 1. Analysis by MALDI-MS of m19 synthetic peptide digested with purified proteasomes. In addi-
tion to m19 substrate, MALDI-TOF analysis detected three different molecular species numbered 1, 2, and 3. In
all cases the sodium adduct and the peptide with an oxidized Met in addition to the sodium adduct were
detected and marked as single asterisk and double asterisk, respectively. Species number 1 could correspond to
either 6 –15 or 5–14 peptides. The m/z number 2 could correspond to either 6 –16 or 4 –14 peptides. Finally, four
different peptides (1–14, 2–16, 3–17, and 4 –18) could have the m/z number 3.
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flat (see “Experimental Procedures”). Thus, several overlap-
ping peptides could co-elute in the same HPLC fraction. A
general limitation of the analysis of complex mixtures by MS
is the inability to discriminate isomers because MS/MS data
are often ambiguous when multiple components are frag-
mented simultaneously. This might explain the limited
improvement obtained with HPLC-ESI-IT over MALDI-MS
analysis. Thus, we studied each one of the 35 theoretical
different peptides that contain the cytomegalovirus 6–14
nonamer core in successive micro-HPLC assays to explore
all possible products of the proteasome activity. Because
only ions of selected mass-to-charge ratio are monitored,
their scan mode generally provides higher sensitivity than
does the full scan mode. Thus, by using micro-LC-MS/MS
with fixed precursor to analyze each theoretical doubly
charged ion derived from m19 sequence and performing a
continuous operation in MS/MS under standard fragmenta-
tion conditions, we can acquire more information on the
studied biological process.
Fig. 3 shows the interpretation of overlapping products
derived from the m19 substrate. Five different molecular ions
could be detected by MS/MS fragmentation of the doubly
charged ion atm/z 810.9. This is the most complex indecisive-
ness that exists among all potential overlapping peptides
derived from the m19 sequence. This m/z corresponds to five
different 14-mers: the 6–19 peptide, both 2–16 and 3–17 pep-
tides with their respective oxidized Met, and the 1–14 peptide
with either Met-1 or Met-10 oxidized. As shown in the inset of
Fig. 3, the mass spectrometer detects a molecular ion with this
m/z range around minute 36 of the HPLC gradient compatible
with the fivemolecular species cited above. The fragment spec-
trum obtained wasmanually interpreted, yielding two different
sequences that satisfactorily matched the pattern of fragment
ions. This analysis discards the presence of three of five candi-
dates and as shown in Fig. 3 demon-
strates the existence of both 1–14
peptides with either Met-1 or
Met-10 oxidized.
Fig. 2 (bottom) summarizes the re-
sults obtained with themicro-HPLC-
MS/MS operating with the parental
ion fixed for all isomeric peptidemix-
tures. The MS/MS fragmentation
spectra were manually interpreted to
identify all co-eluting overlapping
peptides including those present in
lower relative amounts.
Some peptides such as 1–17 were
found in all cleavage experiments
including the negative control with
only the m19 synthetic peptide
without proteases and were not
considered. These results agreewith
some reports (11) that indicate that
Asp-Pro bonds of synthetic peptides
can undergo spontaneous cleavage
under acid conditions such as those
used in solubilization and purifica-
tion of peptides prior to ESI-IT
analysis.
These data show a broad spec-
trum of processed peptides includ-
ing the four previously defined (see
above, Fig. 2) and demonstrate that
the proteasome generates a collec-
tion of peptides where most pep-
tides were N-extended and had the
correct C-terminal Leu.
FIGURE 2. Digestion pattern of m19 synthetic peptide with purified pro-
teasome analyzed by ESI-IT mass spectrometry. The sequence of the cyto-
megalovirus epitope is boxed. The lines show peptide products identified by
MS analysis, and their respective name is indicated. The peptide products
identified by micro-HPLC with on-line detection by ESI-IT MS/MS analysis
were depicted above the m19 amino acid sequence. Similarly, the micro-
HPLC-MS/MS data using analysis of the predefined parent ion were depicted
below the m19 amino acid sequence.
FIGURE 3. Analysis of doubly charged ion at m/z 810.9 by tandem micro-HPLC-MS/MS using the pre-
defined parent ion technique. The IT detector was set to concentrate on the doubly charged ion at m/z 810.9,
performing a continuous operation in MS/MS under standard fragmentation conditions. Total ion counts for
this molecular ion as a function of retention time are plotted in the chromatogram inset. The MS/MS spectrum
obtained from this ion is shown in the lower chromatogram. Asterisks indicate daughter ions common to 1–14
peptides with either Met-1 or Met-10 oxidized that identify the singly oxidized 1–14 peptide but that do not
discriminate the position of oxidation. The differential ions detected for each oxidized peptide are indicated
with respect to the parent ion: m1 for the 1–14 peptide with oxidized Met-1 and m10 for the 1–14 peptide with
oxidized Met-10. Note that differential isomeric daughter ions b6
 and y11
 are both detected from each
oxidation isomer. Ions generated in the fragmentation are detailed at the bottom, and the sequence deduced
from the indicated fragments is shown. m indicates oxidized Met.
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Altogether we suggest the sequential cleavage model
depicted in Fig. 4 as the major pathway followed by the protea-
some. First, the proteasome would cut the m19 peptide
between residues Gly-16 and Asp-17. In a second step, the two
C-terminal residues (Ala-15 and Gly-16) of this product would
be removed. Next, N-terminal Met and Asp residues would be
cleaved. Afterward, the N terminus of this 3–19 product
would continue to be trimmed residue by residue. This
model accounts for three-fourths of the total amount of
detected peptides. It has been proposed that the substrate
interacts with the large inner surface of the proteasome core
at undefined non-catalytic sites (12). In addition, some
authors suggest that the substrate can be covalently attached
to one active site in a transition state complex and then be
attacked in turn by other active sites (13). Therefore, as the
1–14 peptide is the major cleavage product of m19 degrada-
tion (Fig. 1) and we detect mainly N-terminal step by step
trimming, this model suggests that Leu-14 is fixed whereas
adjacent catalytic sites remove sequentially these N-terminal
residues. These N-extended peptides could be trimmed by
aminopeptidases (2). In addition to cleavages inside the
9pp89 epitope, the different prediction algorithms for pro-
teasome activity3 predict the C-terminal cleavage but not the
N-end trimming observed in our experiments.
Alternatively, in each m19 molecule the proteasome may
simultaneously perform two cleavages, one with relaxed speci-
ficity at the N terminus and the other one strongly focused on
the preferred cleavage site after Leu-14.
With three other additional products detected (4–15,
2–16, and 3–17 peptides) no obvious specificity patterns
were found. The most simple explanation could be that
some m19 molecules were cut with a relaxed specificity in
the two cleavages that generates these individual peptides
independently.
In summary, our results show how the identification of
highly related peptidic species in a highly selective and specific
manner is possible and allow its application to elucidate the
mechanisms of antigen processing.
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FIGURE 4. Model of m19 sequential cleavage by the proteasome. The
sequence of the cytomegalovirus epitope is boxed. The lines show peptide
products identified by MS analysis, and the arrows show the model for major
sequential cleavage by the proteasome.
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